Pharma and its regulators

Approvals, trial readouts and the agencies' calendars.

2 newsletters you could start

Already running

A focused newsletter on drug approvals and trial readouts, for people who work in pharmaDaily
A focused newsletter on the FDA's decisions and calendar, for people whose product waits on itWhen something happens